Annual Drug Patent Expirations for OTREXUP
Otrexup is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
Drug patent litigation for OTREXUP.
This drug has thirty-seven patent family members in fifteen countries.
The generic ingredient in OTREXUP is methotrexate. One supplier is listed for this compound. Additional details are available on the methotrexate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
